Current Issue

View Larger Image

Past Issues Free Subscriptions
Sponsored
Keywords



Search Results - Biosimilars
 More »

THIS KEYWORD IS SPONSORED BY:

  • World Biosimilars Congress
    Geneva SWITZERLAND www.terrapinn.com/2013/biosimilars-congress
    11-12-2013
  • Scaleup Issues for Single Use and Steel
    ... Fenge said. "It adapts well to production of biosimilars, the expression of new monoclonal antibody formats, and the need for smaller production quantities." | K. John Morrow Jr., ...
    10-15-2013
  • Fine-Tuning Formulation Processes
    ... Biosimilars: Not Quite an Open Book Formulation of biosimilars is somewhat facilitated by the requirement that manufacturers disclose formulas for all injectable drugs. According ...
    9-15-2013
  • Vela, Evercyte Collaborate on Biosimilar Characterization
    of biosimilars. The partnership expects to provide product-tailored bioassays by combining Vela's expertise in the characterization of biosimilars with Evercyte's ...
    9-3-2013
  • Baxter, Coherus Ink Biosimilar Collaboration Worth Up to $246M
    to generate up to $246 million-will speed up its expansion into the biosimilars market. ... pipeline, which now includes several biosimilars in the areas of immunology and oncology. ...
    9-3-2013
  • Samsung Biologics, BMS in Manufacturing Partnership
    relatively young company, this isn't Samsung Biologics' first major deal: In December 2011, the firm established a joint venture with Biogen Idec to develop and market biosimilars. ...
    7-29-2013
  • Pfizer Splitting Commercial Operations Three Ways, Inks Supply...
    patent-protected products that are expected to lose exclusivity through 2015 in most major markets, biosimilars, and current and future established products collaborations." ...
    7-29-2013
  • Biosimilar Marriage Ends in Divorce for Teva, Lonza
    The companies hoped to bring numerous biosimilars to market and "secure a leading position in the emerging biosimilars market," they said in launching the joint venture in 2009. ...
    7-25-2013
  • Mitsubishi Tanabe Buys Medicago for $357M
    development into other areas such as biosimilars and biodefense products where the ... work on rapid vaccines, expanding into biosimilars, biodefense. Mitsubishi Tanabe Buys ...
    7-12-2013
  • Top 15 Vaccines of 2012
    These top-sellers could be the booster shots the industry needs. You've seen GEN's list of biosimilars to watch ; now, following is a list of 15 vaccines, ranked by sales and ...
    7-2-2013
  • Latest Biosimilar Guidance Raises More Questions
    More than a year after issuing three draft guidances on biosimilars, however, FDA has been ... for developing future policies on biosimilars, including guidance on clinical ...
    6-21-2013
  • Cancer's Bitter Medicine
    ... biologics, for which the regulatory pathway to biogenerics or biosimilars is still in its infancy. Once biosimilars become commonplace for biologics going off patent, we will see ...
    6-15-2013
  • Merck, BMS Immunotherapy Data Whets Clinical Oncology Appetite...
    ... including its axitinib, bosutinib, crizotinib, dacomitinib, inotuzumab ozogamicin, palbociclib, and sunitinib, plus a handful of early-development compounds and biosimilars. ...
    6-3-2013
  • Flexibility in Biopharmaceutical Manufacturing Capacity
    ... products will account for 57% of the global biosimilars market. The cost and complexity of developing and manufacturing biosimilars also suggests that, realistically, product ...
    5-28-2013
  • Cancer's Bitter Medicine
    ... biologics, for which the regulatory pathway to biogenerics or biosimilars is still in its infancy. Once biosimilars become commonplace for biologics going off patent, we will see ...
    5-21-2013

  • Journal Articles

  • The Emergence of Biosimilar Insulin Preparations-A Cause for...
    David Owens, Andrea Schmidt, Wolfgang Landgraf, Reinhard G. Bretzel, Martin K Kuhlmann
    Diabetes Technology & Therapeutics
    are, or shortly will be, off-patent, thereby becoming the focus of pharmaceutical companies interested in attempting to manufacture "copies" commonly described as biosimilars. ...

GEN Webinars

View »

GEN Web Briefs

View »

GEN Poll

More » Poll Results » Archive »

Balancing Family and Career for Women Ph.D.s

Which changes made to academic culture are most likely to encourage women researchers to stay?

Suggest a Poll